Pharma News: Vivus, Inc. (VVUS)’s Contract, Arena Pharmaceuticals, Inc. (ARNA) & Amgen, Inc. (AMGN)’s Financial Results

Page 1 of 2

Editor’s Note: Related tickers: VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Amgen, Inc. (NASDAQ:AMGN), Celgene Corporation (NASDAQ:CELG)

VIVUS, Inc. (NASDAQ:VVUS)VIVUS Announces Commercial Supply Agreement With Sanofi to Produce Avanafil (MarketWatch)
VIVUS, Inc. (NASDAQ:VVUS) -1.13% today announced that it has entered into a Commercial Supply Agreement with Sanofi Chimie (“Sanofi”), a wholly owned subsidiary of Sanofi, to manufacture and supply the active pharmaceutical ingredient (API) for avanafil on an exclusive basis in the United States and other territories and on a semi-exclusive basis in the European Union and Latin America. …”Sanofi was the logical choice for avanafil API manufacturing,” stated Theodore Broman, vice president, chemistry manufacturing and control, VIVUS, Inc. (NASDAQ:VVUS). ”Their world-class manufacturing capabilities and facilities are well-suited to undertake the worldwide production of avanafil.” The qualification and subsequent approval by regulatory authorities is expected to be completed no later than June 30, 2015. Until such approvals, VIVUS, Inc. (NASDAQ:VVUS) and its partners will continue to source avanafil API from Mitsubishi Tanabe Pharma Corporation.

Arena Pharma’s Q2 Earnings Soar (Zacks)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) earnings (excluding special items) of 17 cents per share in the second quarter of 2013 were higher than the breakeven earnings reported a year ago. Second quarter earnings also beat the Zacks Consensus Estimate of 13 cents. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) recorded second quarter revenues of $68.9 million, a massive increase of 213% from the year-ago period, thanks to a $65 million milestone payment received from partner Eisai related to Belviq. In Jun 2013, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) launched its obesity drug, Belviq, in the U.S. Second quarter results reflect the first three weeks of Belviq sales after its launch with Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) recording Belviq sales of $1.3 million. About 12,500 prescriptions for Belviq were written until Jul 19.

Why Has Amgen, Inc. (NASDAQ:AMGN) Stock Suffered Despite Posting Better Earnings? (BasicsMedia)
Amgen, Inc. (NASDAQ:AMGN) has been in business since 1980, during which time it has managed to grow large enough and employ more than 18k personnel. It is based in Thousand Oaks, California and is a well known company in the production of biotechnology medicines which it sells in the U.S, Europe and Canada. For the better part, whenever a company posts financial results which seem to favor investors, it would not be wrong to think of this as being the precursor to good news in terms of stock price and dividends. Amgen, Inc. (NASDAQ:AMGN) appears to have experienced the reverse. Why is this so? Did Amgen, Inc. (NASDAQ:AMGN) Declare Profits or Not? If you take a close look at the financial results which were posted by Amgen, Inc. (NASDAQ:AMGN), you would discover one thing, that they all indicated the company made profits.

VIVUS Announces Date of Second Quarter 2013 Financial Results and Conference Call (Virtual-Strategy)
VIVUS, Inc. (NASDAQ:VVUS) today announced that it will report financial results for the second quarter ended June 30, 2013 after the Nasdaq Market closes on Tuesday, August 6, 2013. The company will conduct a conference call and an audio webcast at 4:30pm EDT the same day. …VIVUS, Inc. (NASDAQ:VVUS) is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity and sexual health. For more information about the company, please visit www.vivus.com.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!